Delayed-type hypersensitivity testing in Tanzanian adults with HIV infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 3, 1996, Pages 303-308

  Miller, William C ^a,d   Thielman, Nathan M ^a   Swai, Nduminsari ^b   Cegielski, J Peter ^a,c   Shao, John ^b   Ting, David ^a   Mlalasi, Juliana ^b   Manyenga, Denis ^b   Lallinger, Gunther J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MUHIMBILI MEDICAL CENTRE   (Tanzania)

^c UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Africa; Delayed type hypersensitivity; HIV infection; Tanzania; Total lymphocyte counts

Indexed keywords

ADULT; ARTICLE; CELLULAR IMMUNITY; CLONAL ANERGY; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN TEST; TANZANIA;

EID: 0030035549     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199607000-00012     Document Type: Article

References (23)

1. World Health Organization. The current global situation of the HIV/AIDS pandemic. Weekly Epidemiol Rec 1994;69: 191-2.
2. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-72.
3. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
4. Blatt SP, Hendrix CW, Butzin CA, et al. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med 1993;119:177-84.
5. Birx DL, Brundage J, Larson K, et al. The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. J Acquir Immune Defic Syndr 1993;6:1248-57.
6. Gordin FM, Hartigan PM, Klimas NG, Zolla-Pazner SB, Simberkoff MS, Hamilton JD. Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. J Infect Dis 1994; 169:893-7.
7. Zeballos RS, Cavalcante N, Freire CA, et al. Delayed hypersensitivity skin tests in prognosis of human immunodeficiency virus infection. J Clin Lab Anal 1992;6:119-22.
8. Fernandez-Cruz E, Desco M, Montes MG, Longo N, Gonzalez B, Zabay JM. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users. AIDS 1990;4:987-94.
9. Royce RA, Luckmann RS, Fusaro RE, Winkelstein W Jr. The natural history of HIV-1 infection: staging classifica-tions of disease. AIDS 1991;5:355-64.
10. Centers for Disease Control and Prevention. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991;40:27-33.
11. Colebunders RL, Lebughe I, Nzila N, et al. Cutaneous delayed-type hypersensitivity in patients with human immunodeficiency virus infection in Zaire. J Acquir Immune Defic Syndr 1989;2:576-8.
12. Mukadi Y, Perriens JH, St-Louis ME, et al. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 1993;342:143-6.
13. + percentage in HIV-infected persons. JAMA 1993;269:622-6.
14. + lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:386-91.
15. World Health Organization. Acquired immunodeficiency syndrome (AIDS): interim proposal for a WHO staging system for HIV infection and disease. Weekly Epidemiol Rec 1990;65:221-4.
16. Kivihya-Ndugga LE, Ochola JJ, Otieno G, Muthami LN, Gathua S. Clinical and immunological markers in Kenyan pulmonary tuberculosis patients with and without HIV-1. East Afr Med J 1994;71:373-5.
17. Ackah AN, Coulibaly D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet 1995;345:607-10.
18. Lifson AR, Allen S, Wolf W, et al. Classification of HIV infection and disease in women from Rwanda: evaluation of the World Health. Organization HIV staging system and recommended modifications. Ann Intern Med 1995;122:262-70.
19. The WHO International Collaborating Group for the Study of the WHO Staging System. Proposed "World Health Organization staging system for HIV infection and disease": preliminary testing by an international collaborative cross-sectional study. AIDS 1993;7:711-8.
20. SAS Institute Inc. SAS/STAT user's guide, version 6. Cary, NC: SAS Institute, 1989.
21. Wartenberg D, Northridge M. Defining exposure in case-control studies: a new approach. Am J Epidemiol 1991;133: 1058-71.
22. Miller WC, Thielman NM, Swai N, et al. Diagnosis and screening of HIV/AIDS using clinical criteria in Tanzanian adults. JAIDS 1995;9:408-14.
23. Guelar A, Gatell JM, Verdejo J, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993;7:1345-9.